Mehdi Razavi, MD

Dr. Razavi is involved with numerous clinical trials assessing the efficacy of cutting edge technology in the field of cardiac electrophysiology. He has founded multiple medical device startups including: Saranas, a smart cardiology sheath, and Nanolinea, conductive nanotechnology for the treatment of arrhythmia. Additionally, Dr. Razavi has supervised the development of a number of technologies in collaboration with Rice University and Texas A&M and has over 20 patents to his name.

See Publications

Texas Heart Institute Positions


  • Medical School:

    Medical College Of Pennsylvania

  • Residency:

    Mayo Graduate School of Medicine

  • Fellowships:

    Mayo Graduate School of Medicine


  • American Board of Internal Medicine, Cardiology (2001, 2011)
  • American Board of Internal Medicine, Clinical Cardiology Electrophysiology (2002, 2012)


Recent News

Saranas’ Early Bird Bleed Monitoring System

Texas Heart Institute Conducting New Clinical Trial to Test Innovative New Early Bird™ Bleed Monitoring System

The Saranas-Owned Technology was invented at Texas Heart Institute. November 20, 2018 (Houston, TX) – Texas Heart Institute is currently...

THI Research Featured on Journal of Cardiovascular Electrophysiology Cover

Dr. Mehdi Razavi and collaborators at THI and UCLA published research in the Journal of Cardiovascular Electrophysiology that was featured on the...

THI & UCLA Discovering New Wireless Power Systems For Novel Cardiac Pacing

Researchers at THI’s Electrophysiology Clinical Research and Innovations Department in partnership with the Department of Electrical and Computer Engineering at the...